APOLLO HOSPITALS | INDRAPRASTHA MEDICAL | APOLLO HOSPITALS/ INDRAPRASTHA MEDICAL |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 109.6 | 18.9 | 580.2% | View Chart |
P/BV | x | 14.5 | 5.6 | 258.8% | View Chart |
Dividend Yield | % | 0.2 | 1.3 | 18.8% |
APOLLO HOSPITALS INDRAPRASTHA MEDICAL |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
APOLLO HOSPITALS Mar-23 |
INDRAPRASTHA MEDICAL Mar-23 |
APOLLO HOSPITALS/ INDRAPRASTHA MEDICAL |
5-Yr Chart Click to enlarge
|
||
High | Rs | 4,901 | 94 | 5,211.1% | |
Low | Rs | 3,366 | 52 | 6,472.9% | |
Sales per share (Unadj.) | Rs | 1,155.4 | 119.9 | 964.0% | |
Earnings per share (Unadj.) | Rs | 61.7 | 9.4 | 656.8% | |
Cash flow per share (Unadj.) | Rs | 104.5 | 13.7 | 764.0% | |
Dividends per share (Unadj.) | Rs | 15.00 | 3.00 | 500.0% | |
Avg Dividend yield | % | 0.4 | 4.1 | 8.8% | |
Book value per share (Unadj.) | Rs | 425.1 | 41.4 | 1,027.1% | |
Shares outstanding (eoy) | m | 143.78 | 91.67 | 156.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.6 | 0.6 | 587.1% | |
Avg P/E ratio | x | 67.0 | 7.8 | 861.8% | |
P/CF ratio (eoy) | x | 39.5 | 5.3 | 740.9% | |
Price / Book Value ratio | x | 9.7 | 1.8 | 551.1% | |
Dividend payout | % | 24.3 | 31.9 | 76.1% | |
Avg Mkt Cap | Rs m | 594,327 | 6,694 | 8,877.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 21,438 | 2,467 | 869.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 166,125 | 10,987 | 1,512.1% | |
Other income | Rs m | 903 | 100 | 900.3% | |
Total revenues | Rs m | 167,028 | 11,087 | 1,506.5% | |
Gross profit | Rs m | 20,496 | 1,507 | 1,360.1% | |
Depreciation | Rs m | 6,154 | 393 | 1,567.1% | |
Interest | Rs m | 3,808 | 43 | 8,897.2% | |
Profit before tax | Rs m | 11,437 | 1,172 | 976.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 2,562 | 310 | 825.7% | |
Profit after tax | Rs m | 8,875 | 862 | 1,030.2% | |
Gross profit margin | % | 12.3 | 13.7 | 89.9% | |
Effective tax rate | % | 22.4 | 26.5 | 84.6% | |
Net profit margin | % | 5.3 | 7.8 | 68.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 43,370 | 2,231 | 1,944.1% | |
Current liabilities | Rs m | 33,249 | 1,296 | 2,564.9% | |
Net working cap to sales | % | 6.1 | 8.5 | 71.6% | |
Current ratio | x | 1.3 | 1.7 | 75.8% | |
Inventory Days | Days | 64 | 18 | 352.9% | |
Debtors Days | Days | 49 | 2 | 2,165.3% | |
Net fixed assets | Rs m | 117,447 | 3,321 | 3,536.9% | |
Share capital | Rs m | 719 | 917 | 78.4% | |
"Free" reserves | Rs m | 60,406 | 2,878 | 2,099.0% | |
Net worth | Rs m | 61,125 | 3,795 | 1,610.9% | |
Long term debt | Rs m | 19,376 | 0 | - | |
Total assets | Rs m | 160,817 | 5,551 | 2,896.9% | |
Interest coverage | x | 4.0 | 28.4 | 14.1% | |
Debt to equity ratio | x | 0.3 | 0 | - | |
Sales to assets ratio | x | 1.0 | 2.0 | 52.2% | |
Return on assets | % | 7.9 | 16.3 | 48.4% | |
Return on equity | % | 14.5 | 22.7 | 64.0% | |
Return on capital | % | 18.9 | 32.0 | 59.2% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0.1 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 118 | NA | - | |
Fx inflow | Rs m | 587 | 1,905 | 30.8% | |
Fx outflow | Rs m | 692 | 360 | 192.5% | |
Net fx | Rs m | -105 | 1,545 | -6.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 13,767 | 1,445 | 952.9% | |
From Investments | Rs m | -8,706 | -1,079 | 806.8% | |
From Financial Activity | Rs m | -6,330 | -260 | 2,430.9% | |
Net Cashflow | Rs m | -1,131 | 105 | -1,075.1% |
Indian Promoters | % | 29.3 | 49.4 | 59.4% | |
Foreign collaborators | % | 0.0 | 1.6 | - | |
Indian inst/Mut Fund | % | 65.4 | 6.0 | 1,092.0% | |
FIIs | % | 45.6 | 1.1 | 4,225.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 70.7 | 49.0 | 144.2% | |
Shareholders | 130,664 | 54,158 | 241.3% | ||
Pledged promoter(s) holding | % | 16.1 | 0.0 | - |
Compare APOLLO HOSPITALS With: DR. LAL PATHLABS METROPOLIS HEALTHCARE KIMS NARAYANA HRUDAYALAYA VIJAYA DIAGNOSTIC
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | APOLLO HOSPITALS | INDRAPRASTHA MEDICAL |
---|---|---|
1-Day | 1.68% | -2.87% |
1-Month | 0.88% | 37.86% |
1-Year | 42.71% | 171.14% |
3-Year CAGR | 25.05% | 62.05% |
5-Year CAGR | 37.99% | 42.69% |
* Compound Annual Growth Rate
Here are more details on the APOLLO HOSPITALS share price and the INDRAPRASTHA MEDICAL share price.
Moving on to shareholding structures...
The promoters of APOLLO HOSPITALS hold a 29.3% stake in the company. In case of INDRAPRASTHA MEDICAL the stake stands at 51.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of APOLLO HOSPITALS and the shareholding pattern of INDRAPRASTHA MEDICAL.
Finally, a word on dividends...
In the most recent financial year, APOLLO HOSPITALS paid a dividend of Rs 15.0 per share. This amounted to a Dividend Payout ratio of 24.3%.
INDRAPRASTHA MEDICAL paid Rs 3.0, and its dividend payout ratio stood at 31.9%.
You may visit here to review the dividend history of APOLLO HOSPITALS, and the dividend history of INDRAPRASTHA MEDICAL.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.